Publication | Closed Access

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial

Neuro-oncologyRadiation MedicineRadiation TherapyGliomaMedicineHigh-grade GliomasClinical Radiation OncologyOncologyRadiation OncologyRadiologyHealth Sciences